Objectives. Clinical guidelines for the use of opioids in chronic noncancer pain recommend assessing risk for aberrant drug-related behaviors prior to initiating opioid therapy. Despite recent dramatic increases in prescription opioid misuse and abuse, use of screening tools by clinicians continues to be underutilized. This research evaluated natural language processing (NLP) together with other data extraction techniques for risk assessment of patients considered for opioid therapy as a means of predicting opioid abuse.
Design. Using a retrospective cohort of 3,668 chronic noncancer pain patients with at least one opioid agreement between January 1, 2007, and December 31, 2012, we examined the availability of electronic health record structured and unstructured data to populate the Opioid Risk Tool (ORT) and other selected outcomes. Clinician-documented opioid agreement violations in the clinical notes were determined using NLP techniques followed by manual review of the notes.
Results. Confirmed through manual review, the NLP algorithm had 96.1% sensitivity, 92.8% specificity, and 92.6% positive predictive value in identifying opioid agreement violation. At the time of most recent opioid agreement, automated ORT identified 42.8% of patients as at low risk, 28 .2% as at moderate risk, and 29.0% as at high risk for opioid abuse. During a year following the agreement, 22.5% of patients had opioid agreement violations. Patients classified as high risk were three times more likely to violate opioid agreements compared with those with low/moderate risk.
Introduction
Chronic noncancer pain is the most common cause of disability and reduced physical, psychological, and social well-being; it is also associated with higher utilization of health care services [1, 2] . An estimated 100 million Americans had chronic pain in 2011, and more than half receive care in primary care settings [3] ; nearly half of those patients are treated with opioid medications by primary care clinicians [4] .
Opioid analgesics play a key role in management of chronic noncancer pain [5] . Emerging data suggest that opioid therapy for chronic pain is associated with an increased risk of serious harms such as overdose, opioid abuse, and mortality [6] . Yet, the past several decades have been marked by a dramatic increase in opioid medication prescribing, dispensing, and use, with a corresponding upsurge in their abuse and diversion [7] .
Clinical guidelines for the use of opioids in chronic noncancer pain recommend risk assessment of aberrant drug-related behaviors (ADRBs) prior to initiating opioid therapy [3, 8] . Despite the dramatic increase in prescription opioid misuse and abuse in recent decades, opioid risk assessment screening tools continue to be underutilized in the primary care setting [3, [9] [10] [11] . Among barriers to adopting opioid practice guidelines, clinicians report inadequate training on pain management [12, 13] , low awareness of/adherence to the guidelines [14, 15] , and time constraints impeding comprehensive opioid management, especially in busy primary care practice [16, 17] .
Among strategies that may mitigate some of these barriers, a recent National Institutes of Health expert panel recommended incorporation of clinical decision support for pain management in the electronic health record (EHR) and use of clinical data in order to better identify patients who may benefit from or are harmed by opioid use [18] . Other investigators from one integrated health care system have successfully applied natural language processing (NLP) techniques to clinical notes and computer-assisted manual review of records to identify clinician-documented problem opioid use [19, 20] , suggesting that semi-automated NLP techniques could be used for identifying problem opioid use among patients on long-term opioids.
The overarching goal of this study was to assess feasibility of an automated risk assessment in chronic noncancer pain patients considered for long-term opioid analgesia. To achieve this goal, we explored the availability of structured and unstructured EHR data and developed and evaluated the NLP algorithm for extracting EHR data relevant to pain management with opioids in a large health care system. In this study, we focused on the EHR data elements needed to populate an existing assessment instrument-the Opioid Risk Tool (ORT) [21] , violation of opioid agreement, and selected ADRBs.
Methods

Setting
This study was conducted at Essentia Health, a regional health care delivery system with a large rural service area in northern Minnesota, northwestern Wisconsin, Patients who had ICD-9 diagnoses of cancer or severe mental health conditions (such as dementia, psychosis, schizophrenia, etc.) prior to their first qualifying opioid agreement were excluded from the study cohort (Supplemental Appendix A). The Essentia Health opioid agreement is valid for 365 days from signing, unless terminated, and is renewed annually. As patients may have had more than one opioid agreement during the study period, this evaluation focused on the most recent opioid agreement signed by each patient during the study window.
Measures of OA Violation and Aberrant Drug-Related Behaviors
The primary outcome was clinician-documented violation of the opioid agreement. In the Essentia Health EHR, the opioid agreement violations could be found either as a code for "violated Essentia Health opioid agreement" in the current health issue listing or as a free-text statement in the clinical note (e.g., "violated opioid agreement," "broken narcotic contract," "breach of a pain contract," "pain medication agreement broken," etc.) Secondary outcomes included four selected ADRBs adapted from the Pain Assessment and Documentation Tool (PADT) [22] documented by clinicians in either structured or unstructured EHR data. Two of the ADRBs were extracted from the clinical notes only: "patient requests early refill of the medication" and "patient reports lost/stolen medications." The other two ADRBs were found either in structured or unstructured sources: "patient abusing alcohol" and "patient is using illicit drugs." The list of illicit drugs included THC/marijuana as it was not legalized during the study period in the study locations. The primary and secondary outcomes were evaluated during a 12-month period following the most recent opioid agreement for each patient in the study cohort.
Two members of the research team (IVH and CMR) conducted manual validation of the NLP process for the primary outcome measure by reviewing clinical notes and determining if a violation of opioid agreement was documented by clinicians. The review included data from 1,590 patients: the 795 identified as NLP positive (cases with presence of opioid agreement violation within unstructured data) and a random selection of 795 NLP negative (cases ruled out by the NLP process). The inter-rater reliability between the reviewers was found to be good (kappa ¼ 0.95, 97.7% agreement for raters) based on the review of the entire sample of the NLP positive cases and a random sample of the same number of NLP ruled-out cases.
Patient Characteristics
Age was calculated at the time of the most recent opioid agreement. ICD-9 diagnosis codes recorded in the structured data prior to the most recent opioid agreement were used to classify chronic pain diagnoses as described in the literature [23] . The conditions were further grouped into chronic musculoskeletal pain or nonspecific chronic pain. A number of chronic pain diagnoses (costochrondritis and intracostal muscle injury, kidney/gall stones, menstrual pain, carpal tunnel, other chronic musculoskeletal pain, and temporomandibular joint disorders) were observed in less than 5% of the cohort and were therefore excluded from individual analyses. A 180-day window prior to the most recent opioid agreement was used to document opioid medication prescription utilization. Opioid medications were classified as short-acting schedule II, long-acting schedule II and nonschedule II [23] . Injections and epidural medications were excluded as these medications are not covered under the Essentia Health opioid agreement. Opioid medication information included medication name, dosage, and administration instructions. If the dosage was not documented, the most commonly used dosage and administration method were used. The daily dose was calculated and converted to oral morphine equivalents (OMEs) using conversion factors adapted from the literature [23] [24] [25] . Based on the OME doses, opioid medication dosing was further categorized [26] as low dose (<40 mg/day OME), medium dose (40-120 mg/day OME), and high dose (>120 mg/ day OME).
Data Extraction
We used two data extraction approaches to identify potential opioid-related problems documented in the EHR. Detailed description of the data extraction methods is available in Supplemental Appendix B. Queries of the Essentia Health Epic EHR relational database were performed to populate structured data tables, including coded entries in the current health care issue listing, encounter-based ICD-9 diagnosis codes, health care encounter information, opioid prescription/dose information, and patient demographics.
Regular-expression NLP techniques were used for extracting unstructured data, such as text in the clinical notes. We developed sets of keywords and phrases for each outcome and the domain of the risk stratification tool. In addition, terms for negation, uncertainty, and references to people other than the patient have been adapted from the open source NLP applications. We also employed approaches discussed in the literature to identify additional negation terms applicable to the subject area of this study [27, 28] . All additional terms were reviewed by at least two members of the research team to decrease the likelihood of "coder bias" and were approved by consensus. These reviews were based on random samples of sentences selected from notes from the 365-day period following signature of the earliest opioid agreement (Supplemental Appendix B).
Automated Opioid Risk Assessment
The ORT was adopted by Essentia Health for clinician use, and therefore it was selected for development of an electronic risk assessment algorithm using EHR data available prior to the most recent opioid agreement. The ORT is a five-domain instrument originally developed to be completed by a patient or a clinician [21] . It was selected for this project due to its simplicity and potential for automating the screening process prior to initiating long-term opioid therapy.
Both structured and unstructured data were used to score all elements of the ORT, except family history of illegal and prescription drugs and history of preadolescent sexual abuse, which were only available in the unstructured data. In addition, patient age was consistently taken from the structured data by design. The ORT score was calculated based on the composite of structured and unstructured data scoring. The default score of zero was assigned to a category if no corresponding data was found. For each ORT category, the maximum of the patient's structured and unstructured category scores was used in the computation of their total ORT score. The total ORT scores were grouped into three categories of risk for addiction potential: low risk (score ¼ 0-3) -unlikely to abuse opioids; moderate risk (score ¼ 4-7) -as likely will as won't abuse opioids; and high risk (score ¼ 8þ) -likely to abuse opioids [21] .
Statistical Analyses
Descriptive statistics were used to summarize study cohort characteristics at the time the most recent opioid agreement was signed. Availability of structured and unstructured data and when both data sources contained matching information for the ORT factors and study outcome variables were reported. ORT factor prevalence gender differences were evaluated using the Pearson chi-square test of significance.
Inter-rater reliability in the manual review of the NLP was conducted using kappa analysis. Based on the review of rater-mismatched cases, a rater agreement was reached and used as a "rater gold standard." Comparison of the NLP assessment with the "rater gold standard" evaluated sensitivity, specificity, positive predictive value, and negative predictive value of the primary outcome NLP assessment. Receiver operating characteristic (ROC) curve analysis was used to calculate the area under the curve (c-statistic), a measure of how well a binary classifier ("violated opioid agreement," yes/no) can distinguish between two conditions. Relationship between ORT risk levels (low, moderate, and high) and the study outcomes was evaluated using the Pearson chi-square test of significance. Logistic regression computed odds ratios and 95% confidence intervals for each study outcome comparing combined ORT low/moderate risk (0-7) to high risk (8þ), both with and without adjustment for the year the most recent opioid agreement was signed.
Results
Of the 11,014 patients with a chronic pain diagnosis during the study period, 4,940 (45%) also had a signed opioid agreement. Of those, 1,268 (26%) were excluded due to preexisting cancer (N ¼ 1,070) or exclusionary serious mental health conditions (N ¼ 198) and four patients were excluded because they were younger than age 18 years at the time of the most recent opioid agreement. The final study cohort included 3,668 patients.
At the time of the most recent opioid agreement, the median age was 48 (25th percentile, 75th percentile ¼ 37, 58) years. Slightly over half of the patients were female (Table 1) . About 83% of the cohort had at least one diagnosed chronic musculoskeletal pain condition, and about 77% of patients had at least one diagnosed nonspecific chronic pain condition. More than two-thirds of the cohort had a diagnosis of general nonspecific chronic pain, nearly half of the cohort had back pain, about one-third of the cohort had pain in joints, and nearly a quarter of the cohort had limb extremity pain. About 5% of patients (N ¼ 188) died during the year following the most recent opioid agreement. Nonschedule II opioids were the most common types of opioids used in this cohort, accounting for 74% (Table 1) . Table 2 shows data availability from EHR-structured and -unstructured sources for the ORT factor scoring. There were no structured data available for family history of illicit and prescription drug abuse or history of preadolescent sexual abuse for females, thus scoring for these ORT factors was based solely on unstructured data. Female patients were more likely to have information about family history of substance abuse (alcohol, illegal drugs) and psychological disease, whereas male patients were more likely to have information regarding personal history of substance abuse (alcohol, illegal drugs). A small proportion of the cohort did not have any EHR data to be used for the ORT scoring (6.8% female and 9.5% male, P ¼ 0.003). Automated ORTbased classification identified 42.8% of the cohort as at low risk (score ¼ 0-3), 28.2% as at moderate risk (score ¼ 4-7), and 29.0% as at high risk (8þ) for aberrant drug-related behaviors. Table 3 reports the availability of EHR data for outcome measures including selected aberrant drug-related behaviors. It should be noted that the majority of patients in the cohort did not have information in the EHR regarding study outcomes. Moreover, compared with NLP only, structured data sources were less likely to reflect violation of the opioid agreement (5.6% vs 16.9%) or alcohol abuse (1.4% vs 13.6%). Table 4 shows prevalence of the outcomes by the ORTbased risk level. Based on the information from all sources, 22.5% of the cohort violated opioid agreement during the follow-up period. There is a clear gradient of higher likelihood of opioid agreement violation among those with higher ORT scores from 11.7% among the low-risk group to 38.7% among the high-risk group. Overall during the follow-up period, 32.2% of the cohort had evidence of the illicit drug use, 15.1% abused alcohol, 5.4% reported lost or stolen prescriptions, and 4.0% had a documentation of requesting early refills. Those who were classified at higher risk had higher prevalence of the secondary outcomes (Table 4) .
Based on the automated ORT stratification, high-risk patients were three times more likely to violate opioid agreement, request early refills, or report lost or stolen prescriptions compared with those classified as low or moderate risk (Table 5) . High-risk patients were also four times more likely to use illicit drugs and five times more likely to abuse alcohol. Adjustment of the logistic regression models for the year of the most recent opioid agreement did not considerably change odds ratios or corresponding 95% confidence intervals.
Discussion
We found that clinical notes of COAT patients are rich sources of unstructured data that can be used to support risk assessment recommended by clinical guidelines. The large volume of clinical notes is a major barrier to clinicians retrieving information relevant for ADRB risk assessment in a timely manner, especially in busy primary care settings. Our findings also suggest that NLP techniques have potential utility to support clinicians in evaluating patients for risk of ADRBs during risk assessment prior to considering long-term opioid therapy or as part of the ongoing monitoring of COAT patients.
Other researchers have also explored the application of NLP techniques to identify and extract information from clinical notes related to problem opioid use [19, 20] . The goal of those research efforts was the use of NLP to better understand and quantify the extent of problem opioid use in a chronic opioid therapy patient population. The current study similarly applied NLP to clinical notes; however, the research goals and outcomes differed. The NLP algorithms developed in this study identified information in unstructured sources needed to populate the ORT and detect opioid agreement violations and selected ADRBs.
The NLP algorithm demonstrated an excellent performance in identifying opioid agreement violations. While it was not practical to manually review all NLP-ruled-out cases, we reviewed all notes for a random sample of the ruled-out cases of the same size as the NLP-positive cases. Observed 96% sensitivity means that 4% of COAT patients who actually violated the opioid agreement were missed by the algorithm. The 93% specificity means that 7% of COAT patients were identified as violating their opioid agreement when they did not.
In this study population, we observed marked variability in the availability of EHR-structured and -unstructured data for elements of the ORT and investigated outcomes during the follow-up period. The NLP algorithm identified nearly four times more COAT patients with opioid agreement violations compared with what was documented in the structured data only. Rates of alcohol abuse documentation were higher in the unstructured sources than the structured sources and similar between the two data sources for illicit drug use. Other considered ADRBs, early refill requests, and reporting of lost/stolen prescription were determined based on the unstructured data sources only and had the lowest rates in this population (4-5%). Of note, the majority of COAT patients did not have information regarding outcome measures during the follow-up OA ¼ opioid agreement; NLP ¼ natural language processing. *Coded as "no" (no mention of), unless otherwise specified. † These outcomes were determined based on the unstructured data review only. window (68-96%), which could be due to either no ADRBs present or lack of documentation of ADRBs in the EHR by clinicians.
We selected the ORT for this study because of its simplicity and potential for automating the screening process prior to initiating long-term opioid therapy. The ORT was developed to predict the risk of ADRBs in patients receiving opioids, was validated on a small sample of patients referred to a pain management clinic [21] , and can be completed by either clinicians or patients. One study found significant differences between the patientcompleted and the clinician-completed ORT [29] , while another reported good correlation between these modes of the ORT administration [30] . In our study, we explored a different mode to populate the ORT using existing EHR data. Similar to the outcome measures, we observed great variability in the availability of EHR data needed for ORT scoring. There were also differences in availability of data between structured and unstructured sources. Looking at the overall ORT factor prevalence, family history of illegal drug and prescription drug abuse and female history of preadolescent sexual abuse were rarely documented. Data for these factors were extracted from the unstructured sources only. Higher factor prevalence rates in the study population were observed for family history of alcohol abuse and personal history of substance abuse (alcohol, illegal drugs, and prescription drugs), with three-to 15-fold more information being extracted from the unstructured sources compared with the structured sources. While we did not conduct a direct comparison of the automated ORT with either patient-or clinician-completed ORT, we did evaluate the effect of the automated ORT on the selected study outcomes and observed a clear gradient of higher likelihood of opioid agreement violation and ADRBs among those with higher ORT scores. Moreover, based on the automated ORT stratification, high-risk patients were three to five times more likely to have negative outcomes during the year following the most recent opioid agreement compared with low-or moderate-risk patients.
This study has several limitations. We used data from only one health care system; moreover, patients and clinicians included in the study were predominantly primary care. Other settings may have different requirements and processes for documentation in the EHR. A replication of our results is needed to confirm their generalizability in other settings. Unlike other studies [19, 20] , we did not have access to opioid prescription fills, and therefore estimated OME daily dosages were based on the prescription information available from the EHR.
We limited our study population to COAT patients who had an opioid agreement in order to maximize our ability to observe the availability of data and test the NLP algorithm. Based on the literature, clinician acceptance of opioid agreements for COAT patients has been slow [31] . More studies are needed for evaluation of the developed NLP algorithm among COAT patients without opioid agreements as the level of documentation in the EHR may be different and could affect the performance of the NLP algorithm.
As this evaluation focuses entirely on what is documented in the EHR, it is possible that information needed to populate the ORT and selected negative outcomes was not recognized by clinicians, and therefore went undocumented. Also, the documentation of the relevant information may have been hindered by attempts of some patients to conceal opioid use-related adverse behaviors and by the unwillingness of some clinicians to document known or suspected ADRBs in the patients' records. Thus, our ability to capture information was limited. Further studies should also compare the automated ORT with other modes of administration.
This study used an innovative approach for both identifying selected ADRBs and scoring an opioid risk assessment tool using information from both structured and unstructured EHR sources. NLP is essential for consistently using free-text clinical information as a basis for clinical decision support. Moreover, the use of NLP directly responds to the expert panel recommendations for incorporating clinical decision support tools and the use of clinical data to better identify patients who may benefit or be harmed by opioid use [18] . As suggested by our findings, this approach may provide clinicians more insight and real-time support for optimal management of chronic noncancer pain patients. Further studies should develop and evaluate a real-time, point-of-care decision support tool for opioid risk assessment of patients considered for long-term opioid therapy.
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